In this study, we examined the cytotoxic efficiency and molecular mechanisms underlying the anticancer activity of curcumin in both DNR-insensitive CD34+ immature AML cell lines and in primary CD34+AML cells. The gene discussed is CD34; the disease is acute myeloid leukemia.